BACKGROUND: There are limited data on the recent trend in the use of optimal evidence-
based medical therapies after acute coronary syndromes (ACSs). We sought to evaluate (1) …

Background—Acute coronary syndrome (ACS) patients in the highest risk categories are
least likely to receive evidence-based treatments (EBTs). We sought to determine why …

BACKGROUND: Coronary heart disease has emerged as a leading cause of death in
China. Although there is strong evidence for the use of antiplatelet, blood pressure …

Objectives. The purpose of this study to determine whether use of cardiac medications
reflects evidence-based recommendations for patients with non–ST elevation acute …

Aims Optimal medical therapy (OMT) is recommended in acute coronary syndrome (ACS)
patients. Few studies present temporal trends of OMT prescription and its impact on …

The objective of this study was to determine the management and outcome of fewer selected
patients with an acute coronary syndrome during hospitalization and up to 1 year after …

BACKGROUND: Only limited data are available for the recent trend of optimal evidence-
based medical therapy at discharge after acute myocardial infarction (AMI) in Asia. We …

Use of evidence-based medicine (EBM) improves outcomes after acute coronary syndromes
(ACS), yet patients often discontinue prescribed therapies after discharge. Although such …

BACKGROUND: Acute coronary syndrome includes life-threatening clinical conditions
ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial …

Several medications have individually been shown to reduce mortality in patients with acute
coronary syndromes (ACS), but data on long-term outcomes related to the use of …